Biocon Announcements
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund
20 Jan, 2026 | 10:07am • Source: BSE
Qualified Institutions Placement - Allotment
14 Jan, 2026 | 11:49pm • Source: BSE
Qualified Institutions Placement - Allotment
14 Jan, 2026 | 11:48pm • Source: BSE
Qualified Institutions Placement - Approval and adoption of Placement Document
14 Jan, 2026 | 10:30pm • Source: BSE
Qualified Institutional Placement - Issue Opening
14 Jan, 2026 | 10:13pm • Source: BSE
Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve...
13 Jan, 2026 | 04:54pm • Source: BSE
Qualified Institutional Placement - Issue Opening
12 Jan, 2026 | 04:47pm • Source: BSE
Intimation of approval of Unaudited Condensed Consolidated Interim Financial Statements
12 Jan, 2026 | 04:08pm • Source: BSE
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
08 Jan, 2026 | 06:37pm • Source: BSE
Intimation of Record Date for Commercial Paper
08 Jan, 2026 | 01:53pm • Source: BSE
Press Release
06 Jan, 2026 | 05:36pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mylan Inc
06 Jan, 2026 | 09:38am • Source: BSE
Acquisition of equity share of Biocon Biologics Limited
05 Jan, 2026 | 09:51pm • Source: BSE
Allotment of equity shares on a preferential basis
05 Jan, 2026 | 09:48pm • Source: BSE
Intimation of early full redemption of NCDs by the Company
05 Jan, 2026 | 12:31pm • Source: BSE
Issue of Commercial Papers of Rs. 200 Crores
02 Jan, 2026 | 04:48pm • Source: BSE
Voting results and Scrutinizer''s report of the EGM
01 Jan, 2026 | 11:23am • Source: BSE
Proceedings of the Extra-Ordinary General Meeting of the Company
31 Dec, 2025 | 06:13pm • Source: BSE